NAD+ buying guide
The price that ends: first-month NAD+ prices, and what replaces them
Some of the lowest NAD+ figures published anywhere are charged exactly once. They are not discounts off an ongoing price so much as a different price with a shorter life, and the interesting question is not how low they go but whether the seller says what happens next.
A first-month price is a price with an expiry
A first-month price is not a discount in the ordinary sense. It is a different price with a shorter life: charged once, at the start, and replaced by something else afterwards. Sellers write it in a dozen ways — “first month”, “/first mo.”, “(For the first month)”, “First order discount” — and this index stores each wording exactly as printed, because the wording is the only thing that distinguishes it from a standing rate.
It matters more here than it would in most markets. NAD+ is sold on subscription, so the number a buyer commits to is almost never the number they first pay, and the gap between the two is sometimes large.
How many, and how many sellers
27 of the 382 figures read for this index are first-period prices, published by 11 of the 110 sellers. Separately, 17 figures carry a billing period that is itself only a first period — a seller saying, in the field where a cycle should go, that this applies once.
Both counts are small next to the 382, and the sellers who use the device are not the fringe of the roster. Several of the ones below run the whole of their published pricing on it.
The sellers who print what comes next
The best case for a reader is a seller who prints both numbers in one sentence. There is nothing to work out, nothing to match up, and nothing this site has to infer.
| Seller | The sentence, as printed |
|---|---|
| HealthOn | “Monthly Plan Billed and shipped monthly. $173 first month $196/mo after” |
| HealthOn | “3-Month Plan Billed every 3 months. Shipped monthly. $119 first month $186/mo after” |
| Brightmeds | “From $105 first month | then $155/mo*” |
| NativeMed | “Sale price $159.00 first month then $186/mo*” |
| TeleZen MD | “Compounded NAD+ Nose Spray 300 MG/15 ML Monthly Plan $98 first month $148/month after” |
| Sprout Health | “Monthly PLAN 1000mg (5mL vial) Enjoy flexibility + a first month discount $199 / first month $249 /mo after” |
| AgelessRx | “$79/first month Applies to 3-month plan billed in full ($149/mo after)” |
| Pallas Health | “Nasal spray: $79 for your first month, then $567 every 12 weeks ($189/mo average).” |
Pallas Health is the row to read twice. It is the only one whose “after” figure is not a monthly charge: $567 every twelve weeks is what is billed, and the $189 beside it is the seller’s own average. An average is arithmetic, not a charge, so the $567 is the price here and the $189 is not.
Source: Every cell is the seller’s own sentence around the figure. Both numbers in a row come from that one sentence; neither is paired by inference. Read September 2026.
The Brightmeds review separates the first-period and later figures recorded on September 4, 2026, including several plan options. Compare the two charges for the same plan, then confirm its billing commitment before buying. A lower first payment alone does not establish the cost of staying enrolled.
Two of those rows repay a second look. Brightmeds moves from $105 to $155 a month, which is roughly a half again. AgelessRx’s $79 is not a standalone month at all — its own sentence says it applies to a three-month plan billed in full, so the $79 is the first month of a commitment rather than a month you can buy on its own.
The sellers who print no ongoing price at all
Then there is the other case, and it is the one worth coming to this page for.
| Seller | Everything it publishes |
|---|---|
| System Labs | “$119 $69 /first mo.” and “$149 $89 /first mo.” — two struck-looking pairs. Only the lower figure in each carries a label, and the page states no price after the first month |
| RxSpan MD | “Nicotinamide Adenine Dinucleotide ( NAD+ ) Injection $249 (For the first month)”, and the same wording for a nasal spray at $249 and a tablet at $199. No second-month figure appears on any of them |
These are the sharpest rows on the site, and they have to be shown as an absence rather than as a jump: you can find out what the first month costs and not what the second one costs. That is a fact about the page, not a judgment about the company.
Source: Every figure these two sellers publish is listed, each with the sentence printed around it. Read September 2026.
Neither seller is doing anything unusual by the standards of this market. What they are not doing is telling a reader what the product costs. A first-month price with no stated second month is a figure that answers a question nobody asked in place of the one everyone does.
Why this index will not pair them up for you
The tempting move on a page like this is a table with two columns, intro and ongoing, for all 11 sellers. It can be computed: take each first-period figure and pair it with the lowest standing rate the same seller publishes. It was computed, as a check, and it failed its own sanity test — in four of nineteen derived pairs the “ongoing” figure came out lower than the introductory one.
A result like that does not mean four sellers charge less later. It means the pairing was wrong: the seller publishes several products, or several plan lengths, and the cheapest standing rate belonged to a different one. Publishing the table anyway would have printed fifteen right answers and four confident wrong ones, all in the same typeface.
So the pairs on this page are only the ones the sellers made themselves. Every seller’s review page lists all of its figures with the kind and the wording attached, which is the honest way to see what a particular company charges after the first month: read what it printed.
What this page cannot tell you
It cannot tell you the ongoing price for every seller with an intro offer. For some of them that number is not published; for others it is published in a way that does not attach to the intro figure, and this index will not attach it for them.
It also cannot tell you what a first month includes that a later one does not, or the reverse. Whether a first payment covers a consultation, a lab test or a longer supply is not something this index has a field for, and the commitment behind a figure is a separate question with its own answer. Source readings: September 2026 to October 2026 for the introductory offers counted here. Historical quotations retain their own source dates.
When a seller prints two figures side by side with nothing linking them, which one is the price? Both figures are kept here, and nothing says the two are a pair or that they contradict each other.
A record of which figure goes with which, written down while the page is being read. It is a matter of shape rather than one more value: nothing here can hold a disagreement between two figures, which is why figures that disagree are marked unresolved one at a time instead of as the pairs they are.
Which named plan does a figure belong to? A seller publishing four figures usually names them — a monthly plan, a three-month plan, a starter tier — and what is held here is the figure, the billing cycle and the dose, not the seller's own name for the package.
Someone reading each page again and writing down the plan name beside each figure, word for word. Until that happens, two figures from one seller can be seen to differ without anything saying what the seller called each one.
To inspect the seller-level evidence, open the AgelessRx review for its first-period and plan wording, or the RxSaludable review for the introductory and later figures recorded together. The RxSpan MD review shows the different case: first-month figures without an established ongoing price in this reading.
Read next
About this page
Nothing here is medical advice, diagnosis or treatment. This is a price index, and pages like this one exist because a reader cannot judge a price without knowing what the thing is. Talk to a licensed clinician before starting or stopping anything, and see the medical disclaimer.
Every count above comes from reading 110 sellers’ own pages, and each one is worked out again every time this page is built, so it cannot drift from the tables and the reviews it is drawn from. If something here is wrong, the corrections page says how that gets fixed and what has been fixed before.
Where these figures come from
These counts describe the recorded pricing information for 110 NAD+ sellers: 382 figures in all, representing 350 distinct offers after 32 repeat observations of the same offer are set aside. Of the recorded figures, 41 appear only in page markup, rather than visibly on the seller’s page.
Current source readings span September 2026 to October 2026. Each price retains the date of its own source observation. A latest source date does not mean that every provider was checked again then. Earlier price checks are retained for 14 of the 110 providers; their review pages show those readings separately. A source period alone does not establish that a price rose, fell or stayed the same.
Each seller has a pricing review showing recorded prices or quote status, original payment qualifications and source dates, including labels for figures found only in markup. We retain the underlying merchant source records internally. Reviews show the recorded pricing evidence and link through to the provider so you can confirm current terms.